怀孕早期心脏代谢指数与使怀孕复杂的高血压障碍之间的关系
Zakir Ullah Khan1, Shakir Ullah Khan2, Musaira Tariq3
1Cardiology, Russells Hall Hospital, Dudley, GBR.
Cureus
|January 11, 2024
概括
怀孕早期心脏代谢指数与孕前风险有关. 怀孕早期心脏代谢指数值较高与患子宫前的可能性增加有显著的相关性.
科学领域:
- 产科和妇科 产科和妇科
- 心脏病学 心脏病学
- 代谢健康 代谢健康
背景情况:
- 怀孕期间的高血压,特别是产前,对孕妇和胎儿构成重大风险.
- 早期识别子宫前风险因素对于及时干预至关重要.
- 心脏代谢指数 (CMI) 是代谢健康的新兴标志物.
研究的目的:
- 在高血压妇女中研究怀孕早期心脏代谢指数.
- 为了确定早期怀孕CMI和产前的发病率之间的关联.
- 探索CMI和不同程度的孕前症严重程度之间的关系.
主要方法:
- 一项病例对照研究,涉及289名孕妇患有先兆子和289名健康孕妇对照.
- 临床数据的比较,包括体重指数 (BMI),血压,腰围和甘油三水平.
- 分析早期怀孕CMI和产前发生之间的关联,控制年龄和BMI.
主要成果:
- 在CMI四分位数和孕前患者的比例之间发现了显著的关联 (p < 0.001).
- 怀孕前的风险仍然显著上升,CMI更高,即使在调整年龄和BMI后.
- 在早期怀孕CMI和产前的发生之间观察到正相关性.
结论:
- 怀孕早期心脏代谢指数升高是孕前的重要预测因素.
- CMI可以作为一个有价值的生物标志物来评估妊娠前风险.
- 需要进一步的研究来探索CMI在妊娠并发症中的作用.
相关概念视频
Pathophysiology of Diabetes
940
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
940
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
93
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
93
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Psychoneuroimmunology: Cardiovascular Disease
31
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
31
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K


